Insulet Corp. (PODD)
145.42
-2.74
(-1.85%)
USD |
NASDAQ |
Aug 24, 16:00
145.50
+0.08
(+0.06%)
After-Hours: 20:00
Insulet Net Income (Quarterly) : 95.00M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 95.00M |
| March 31, 2026 | 91.10M |
| December 31, 2025 | 101.60M |
| September 30, 2025 | 87.60M |
| June 30, 2025 | 22.50M |
| March 31, 2025 | 35.40M |
| December 31, 2024 | 100.70M |
| September 30, 2024 | 77.50M |
| June 30, 2024 | 188.60M |
| March 31, 2024 | 51.50M |
| December 31, 2023 | 103.30M |
| September 30, 2023 | 51.90M |
| June 30, 2023 | 27.30M |
| March 31, 2023 | 23.80M |
| December 31, 2022 | 17.00M |
| September 30, 2022 | -5.20M |
| June 30, 2022 | -35.00M |
| March 31, 2022 | 27.80M |
| December 31, 2021 | 29.20M |
| September 30, 2021 | 12.60M |
| June 30, 2021 | -25.00M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -17.10M |
| September 30, 2020 | 11.60M |
| June 30, 2020 | 14.40M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.10M |
| December 31, 2019 | 5.00M |
| September 30, 2019 | 0.852M |
| June 30, 2019 | 1.402M |
| March 31, 2019 | 4.378M |
| December 31, 2018 | 9.893M |
| September 30, 2018 | 1.659M |
| June 30, 2018 | -1.691M |
| March 31, 2018 | -6.569M |
| December 31, 2017 | -6.86M |
| September 30, 2017 | -2.227M |
| June 30, 2017 | -7.767M |
| March 31, 2017 | -9.977M |
| December 31, 2016 | -9.153M |
| September 30, 2016 | -3.017M |
| June 30, 2016 | -4.351M |
| March 31, 2016 | -10.69M |
| December 31, 2015 | -27.33M |
| September 30, 2015 | -17.98M |
| June 30, 2015 | -15.43M |
| March 31, 2015 | -11.83M |
| December 31, 2014 | -5.40M |
| September 30, 2014 | -10.84M |
| June 30, 2014 | -29.11M |
| March 31, 2014 | -6.144M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 928.00M |
| DexCom, Inc. | 249.10M |
| Boston Scientific Corp. | 905.00M |
| PROCEPT BioRobotics Corp. | -26.86M |
| Globus Medical, Inc. | 151.57M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 801.70M |
| Total Expenses (Quarterly) | 706.70M |
| EPS Diluted (Quarterly) | 1.066 |
| Enterprise Value | 10.50B |
| Gross Profit Margin (Quarterly) | 72.56% |
| Profit Margin (Quarterly) | 11.85% |
| Earnings Yield | 3.47% |
| Operating Earnings Yield | 5.05% |
| Normalized Earnings Yield | 3.407 |